Putri A, Rinaldi I, Louisa M, Koesnoe S. The Role of STAT5 in Tyrosine Kinase Inhibitor (IMATINIB) Resistance in CML Patients. Acta Med Indones [Internet]. 2020Feb.10 [cited 2025Nov.17];51(4):348. Available from: http://www.actamedindones.org/index.php/ijim/article/view/978